Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Predictive Oncology Inc. (NASDAQ: POAI) Industry Leader in Growing Precision Medicine Market

Recent study reports CAGR of 9.7% in precision medicine space. Predictive Oncology focused on use of data, artificial intelligence to develop personalized cancer therapies. One of POAI’s primary projects is building multi-omic predictive models of tumor drug response A recent study of the global precision medicine market indicates a bright future for the industry, especially […]

Gage Cannabis Co. Announces Pre-IPO Financing Round, Early Opportunity to Invest in Top Operator

Round of financing led by Bruce Linton, executive chairman of Gage Cannabis and cannabis industry pioneer Reg A+ equity financing offers chance to invest in exclusive cultivator, processor, and retailer of world-leading cannabis brands First step in Gage’s journey to becoming publicly traded company Gage Cannabis Co., the leading high-quality craft cannabis brand and operator […]

Pac Roots Cannabis Corp. (PACR) Set to Benefit as Hemp and Cannabis Producers Evolve, Differentiate Crop Cultivation

Pac Roots Cannabis Corp. specializes in creation of unique, proprietary cannabis and hemp strains Following its tie-up with Phenome One Corp, Pac Roots offers over 350 meticulously designed cultivars possessing wide array of characteristics Introduction of patent protection on genetically modified hemp strains along with insurance provided to hemp growers incentivizes hemp production, drives greater […]

SRAX Inc. (NASDAQ: SRAX) Spinoff BIGtoken(R) Inc. Announces George Stella as Chief Revenue Officer

George Stella appointed chief revenue officer of BIGtoken following executive vice president tenure at SRAX SRAX moving BIGtoken to separate publicly traded company through definitive share exchange agreement with Force Protection Video Equipment Corp BIGtoken platform compensates over 16 million users for data that marketers access for fee BIGtoken(R) Inc., a former SRAX (NASDAQ: SRAX) […]

Rritual Mushrooms Inc. Takes Aim at New Wellness Industry in Functional Foods Marketplace

Rritual Mushrooms Inc. is an emerging producer of premium plant-based superfood products designed to help people meet the demands of modern life with style and ease The company introduced the wellness and nutraceuticals market to its suite of three mushroom and adaptogen-based elixir powders in September Rritual Mushrooms’ products were created to boost immunity, support […]

AzurRx BioPharma Inc. (NASDAQ: AZRX) is “One to Watch”

AzurRx BioPharma’s lead therapeutic, MS1819, is a recombinant lipase treatment for exocrine pancreatic insufficiency and is currently targeting patients with cystic fibrosis and chronic pancreatitis – an established global market of more than $2 billion The company is currently pursuing parallel monotherapy and combination therapy trials, which are anticipated to produce topline data in Q1 […]

Pure Extract Technologies Inc. Leveraging Growing Popularity of Medicinal Mushrooms in Mainstream Medicine

Scientific research suggests some mushrooms can provide mental benefits, anti-tumor effects, improved immune function, anti-viral properties and detoxification “Psychedelic” varieties currently being studied for depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease, addiction Pure Extracts is expanding into functional mushroom market; Company is currently licensed by Health Canada to buy, sell, produce cannabis products Mushrooms have […]

180 Life Sciences Corp. Bringing Hope to Those Afflicted by Dupuytren’s Disease and Other Inflammatory Conditions

180 Life Sciences is a clinical-stage biotechnology company developing anti-tumor necrosis factor (“TNF”) therapies to treat a variety of inflammatory conditions. Phase 2b/3 clinical trials on fibrosis and inflammation-causing TNF irregularity are currently underway with first results expected in 2021 The company is to be acquired by a SPAC (NASDAQ: KBLM) and will be listed […]

 

From Our Blog

Where Geology Creates Advantage: Inside Search Minerals Inc.’s (TSX.V: SMY) (OTC: SHCMF) Development Across Labrador’s Rare Earth Districts

December 12, 2025

Disseminated on behalf of Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) and may include paid advertising. Search Minerals (TSX.V: SMY) (OTC: SHCMF), a mine exploration and development company, is working hard to advance Canada’s strategically positioned rare earth portfolio.  The company controls two districts: the Port Hope Simpson – St. Lewis CREE District and the […]

Rotate your device 90° to view site.